Clinician-to-Clinician Update Clinician-to-Clinician Update

Cancer Care

University of Minnesota Cancer Care is driven to lead and advance patient care and treatment options through innovative clinical research and multidisciplinary collaboration. Learn about our comprehensive cancer care services.

February 2018


Collaborative Care, New Therapies Improve Neurofibromatosis Outcomes

NF patients are at increased risk of additional tumors and cancers. Clinical and research collaborations, novel drugs, and MRI-guided procedures aim to improve outcomes for these patients.

Continue reading

MRI-Guided Biopsy and Laser Ablation of a Difficult-to-Access Brain Tumor

A young patient with neurofibromatosis 1 seeks a second evaluation of a deep brain lesion. An MRI-guided biopsy enables laser ablation of the tumor. The patient recovers with no neurological deficit.

Continue reading

Cancer Care Specialty Updates

New head of neurosurgery is named, and a new research model looks to advance testing of NF therapies. Clinical trials of cancer and NF therapies open to enrollment.

Continue reading

October 2017

Consult-October-2017-GI-Cancer-Feature-Article-Feature-Image- 536907319

Immunotherapy Shows Promise in Reducing Urothelial Cancer Mortality

While chemotherapy is the first-line treatment for advanced urothelial cancer, checkpoint inhibitors have shown success in patients with bladder cancer. Clinical trials are testing their further use.

Continue reading
Consult-Cancer-Care-October-2017-Case-study-Feature-Image- CT-scan before

Therapy with Nivolumab Induces Remission in Advanced Urothelial Cancer Case

After a patient’s cancer progresses on various treatments, he opts for a clinical trial immunotherapy. At 3 months of therapy, he experiences a near complete radiographic response and resolution of pain.

Continue reading

Cancer Care Specialty Updates

Clinical trials testing immunotherapies for bladder cancer are now available through University of Minnesota Health physicians, including a Masonic Cancer Center-sponsored investigation into a neoadjuvant therapy.

Continue reading

July 2017


New Approaches to Managing Difficult-to-Treat Sarcomas

Sarcomas, including liposarcoma, present treatment challenges. Recent studies, however, are uncovering the possible benefits of presurgical radiotherapy and new methods for better identifying treatment.

Continue reading

Neoadjuvant Radiotherapy for Myxoid Liposarcoma Shows Pathologic Response

Radiotherapy prior to surgery produces clinical benefit for a patient with liposarcoma, rendering the tumor nonviable. Management of his condition required local and systemic treatments.

Continue reading

Cancer Care Specialty Updates

Presurgical radiotherapy shows benefit in treating sarcoma, and 2 new clinical trials open. The foundation Rein in Sarcoma announces its annual fundraiser. Learn more.

Continue reading

April 2017


Novel Treatment Regimens Improve Survival Rate in Multiple Myeloma

With the help of University of Minnesota Health physicians, advances in drug development and clinical trials have established the current standard of care for patients with newly diagnosed multiple myeloma.

Continue reading

Autologous Stem Cell Transplant Sends Patient’s Myeloma into Remission

A new treatment regimen and modified maintenance therapy help keep the patient’s multiple myeloma in complete remission 3 years after transplant.

Continue reading

Cancer Care Specialty Updates

A trial testing dendritic cell vaccine for multiple myeloma opens, joining clinical trials assessing new maintenance and consolidation therapies. Learn more.

Continue reading

February 2017

Feb-2017-Melanoma-Feature-Article-Feature-UMMC CancerCare CSC DR Tuttle PT Tene 112916 219

New Surgical Approaches and Therapies for Melanoma Improve Outcomes

A minimally invasive approach to dissecting affected inguinal lymph nodes and new immunotherapies under clinical trial review show promise in treating an increasingly common form of cancer.

Continue reading

Endoscopic Lymph Node Dissection Arrests Melanoma with Minimal Scarring

A patient with melanoma undergoes a minimally invasive femoral lymph dissection. Discharged the same day, she experienced no wound complications and remains free of melanoma recurrence.

Continue reading
Feb-2017-Melanoma-Consult-Spec-Updates-Feature-Image-Domingo-Musibay Evidio 18313217856 MH Bio

Cancer Care Specialty Updates

A University of Minnesota Health oncologist serves as a site principal investigator on a study into melanoma treatment patterns. Read more and learn about a new dermatologic surgeon joining the M Health team.

Continue reading

October 2016

Oct-2016-Consult-Main-Article-Feature-Image-150319 UMF 280

Speeding the Development of Breast Cancer Therapies

A new clinical trial model draws on a database of multisite study findings to advance the discovery of new therapies. The approach is beginning to identify new drugs for difficult to treat breast cancers.

Continue reading
Oct-2016-Cancer-Care-Consult-Case-Study-Feature-Image-004101 00 N4 letter

Experimental Therapy Aids Patient with Triple-Negative Breast Cancer

A novel drug combined with standard-of-care chemotherapy provides a successful outcome for a clinical trial participant. The drug therapy is being further evaluated in a phase III trial.

Continue reading
Oct-2016-Consult-Specialty-Updates-Feature-Image-Hui Jane 1396186078 MH Bio

Cancer Care Specialty Updates

A surgical oncologist joins the M Health Cancer Care team, and a new study sheds light on a breast cancer therapy’s link to increased risk of cardiovascular disease.

Continue reading

September 2016


New Research Center Targets Spreading Cancers

University of Minnesota research center brings together biophysicists and cancer specialists in the study of rapidly spreading cancers. Initial investigations will focus on glioblastoma cells.

Continue reading
Sept-2016-Neuro-Onc-cancer-cell GkdVLddO20 contactRhondaZurn

Awake Craniotomy with Speech Mapping Allows Patient to Return to Work

Intraoperative mapping of patient’s brain enables resection of a large, infiltrative tumor while preserving the patient’s speech function.

Continue reading

Cancer Care Specialty Updates

Clinical trials evaluate drug therapies in the treatment of embryonal or germ cell tumors, and a neuro-oncologist joins the specialty team.

Continue reading

May 2016


Exploiting the Immune Response to Treat Patients With Cancer

University of Minnesota Health physician-researchers keep improving the use of natural killer cells in the fight against cancer.

Continue reading

April 2016


Preventing Cancers Caused by Human Papillomavirus

The HPV vaccine could potentially reduce HPV-induced cancers by one-third, yet vaccination rates lag. An M Health physician helps lead an initiative designed to support physicians in encouraging use of the vaccine.

Continue reading

Study Undertakes Systems-Based Approach to Increasing HPV Vaccination Rates

Part of the work of Minnesota HPV, the study equips community healthcare providers with toolkits designed to help them in working with young patients and their families.

Continue reading

Cancer Care Specialty Updates

Discover two cancer care-provider events, including the Minnesota HPV Vaccination Summit to be held April 25 on the University of Minnesota campus. Find event and registration details.

Continue reading

February 2016

CFGr953 4C

Promising New Treatments for Gastrointestinal Cancers

A new method of chemotherapy and Minnelide, the breakthrough therapy identified by University of Minnesota cancer researchers, may improve outcomes for patients with these challenging cancers.

Continue reading
CT-scan case-study CC-Consult-Feb2016

Resection of Pancreatic Cancer Previously Considered Inoperable

Advancements in surgical techniques and imaging allow the resection of a pancreatic tumor and a section of the involved veins. At 1-year follow-up, the patient reports a good quality of life.

Continue reading

Cancer Care Specialty Updates

Discover three now-enrolling clinical trials testing therapies for patients with advanced, metastatic pancreatic cancer.

Continue reading

October 2015

20141222 BachanovaVallera 023-10-7-v.2

New Therapies for Hematologic Malignancies Show Promise

Masonic Cancer Center, University of Minnesota trial suggests that a new treatment for refractory B-cell malignancies may be on the horizon. A separate study shows promising findings for patients with lymphoma.

Continue reading
97934-Fig-1-Hem-Cancers-Consult cropped-v.1-homepage

Patient with Refractory CLL Achieves Durable Response in Immunotoxin Trial

An 80-year-old woman with refractory chronic lymphocytic leukemia experienced a 40% reduction in tumor size after treatment with a novel immunotoxin. At 15-months follow-up, the patient remains in partial remission.

Continue reading
Miller-Jeffrey Consult Hem-issue-Home-Page2

Cancer Care Specialty Updates

Researcher receives national recognition, and a clinical trial of a therapy for non-Hodgkin lymphoma is announced. Learn about the trial and the award of National Cancer Institute research grants.

Continue reading

July 2015

Topic FluorescentCystoscopy BadrinathKonety 974x645

Latest Diagnostic and Screening Tools for Genitourinary Cancers

Discover how new technology is improving the detection of bladder and prostate tumors and allowing for their more complete resection.

Continue reading
prostate-ultrasound Fig1-443x293

MRI/Ultrasound Fusion Biopsy Reveals Advanced Cancer after Prior Negative Tests

Biopsies on a patient with a history of obstructive urinary symptoms and rising PSA levels produced only negative results. Using a new MRI-ultrasound technology, surgeons were able to locate lesions and successfully treat for prostate cancer.

Continue reading

Cancer Care Specialty Updates

University of Minnesota Cancer Care has announced a clinical trial to test the proposition that MRIs of a higher 7-Tesla field strength will provide increased sensitivity to prostate cancer metabolic markers that are not detectable at lower-field strengths.

Continue reading

May 2015


Minimally Invasive Thoracic Cancer Surgery Reduces Complications

Research comparing outcomes of thoracic cancer patients indicates that minimally invasive techniques are associated with improvements in morbidity rates, lengths of hospital stay, and postsurgical pain.

Continue reading
Intraop-image Podgaetz-case-study-443x299

Aggressive Surgery for Complete Resection of Rare Thoracic Cancer

A 25-year-old, active male patient with a large and fast-growing mediastinal germ cell tumor was successfully treated with chemotherapy and an aggressive, complete tumor resection.

Continue reading
Podgaetz-left-Andrade Thoracic-surg-443x295

Cancer Care Specialty Updates

The University of Minnesota Cancer Care lung-screening program is named a center of excellence. Find this and other UMN Cancer Care news.

Continue reading

April 2015


Expediting Treatment for Patients with Acute Myeloid Leukemia

Research shows that only 20-25% of adult patients with AML will be cured by chemotherapy alone. Learn how a BMT may offer the best chance for a cure. 

Continue reading

Personalizing Treatment for Patients with Myelodysplastic Syndromes (MDS)

For patients with MDS, disease severity can range low impact on their quality of life, to severe, with severely low blood counts, recurrent infections and increasing risks of progression to AML. BMT is currently the only cure.

Continue reading

New Clinical Trials Aimed at Improving Bone Marrow Transplant Results

Learn about new clinical trials for patients with AML and MDS.

Continue reading

February 2015

chart 974

Technological Breakthroughs in Minimally Invasive Head and Neck Cancer Surgery

Discover how advances in robot-assisted and endoscopic endonasal surgeries are lessening the impact of head and neck cancer surgery.

Continue reading
preop 443

Middle-aged Male Patient Remains Tumor Free 3 Years After Endoscopic Endonasal Surgery

The technique allowed for a total resection of the patient’s sino-nasal tumor with no facial or skull incisions. The patient was discharged four days after surgery and has returned to normal activities.

Continue reading
Khariwala-Samir 443

Head and Neck Cancer Specialty Updates

UMN Health surgeon honored. Learn more and find news on two current clinical trials and a cancer-survivor conference.

Continue reading

November 2014


Early Cancer Detection and Prevention for At-Risk Individuals

Our Cancer Risk Management Program helps patients evaluate their risk of developing cancer and to work with them and their referring healthcare providers to manage cancer risk over the long term.

Continue reading
pedigree 443x2951

Sisters With Early Endometrial Cancer Diagnoses Discover Inherited Syndrome

Lynch syndrome, a dominantly inherited cancer syndrome, confers a predisposition to colorectal, endometrial, and other cancers. A patient's offspring and/or siblings have a 50% chance of inheriting it.  

Continue reading

Cancer Care Specialty Updates

Learn more about our web-based risk assessment for ovarian cancer patients, our newest locations and a new tool to identify breast cancer risk.

Continue reading
Load More